-
Faecalibacterium prausnitzii is associated with clinical response to immune checkpoint inhibitors in patients with advanced gastric adenocarcinoma: results of microbiota analysis of PRODIGE 59-FFCD 1707-DURIGAST trial Gastroenterology (IF 25.7) Pub Date : 2024-10-23 Marius Bredon, Karine le Malicot, Christophe Louvet, Ludovic Evesque, Daniel Gonzalez, David Tougeron, Harry Sokol
No Abstract
-
Burn the fat: colon cancer tumors are skilled at lipid storage during obesity Gastroenterology (IF 25.7) Pub Date : 2024-10-23 Arianne L. Theiss, Christopher S. Williams
No Abstract
-
Assessing the Preventative Effects of Vonoprazan Relative to Intravenous Proton Pump Inhibitors Following Endoscopic Intervention in Peptic Ulcers Gastroenterology (IF 25.7) Pub Date : 2024-10-22 Wei-Zheng Tang, Tai-Hang Liu, Ying-Bo Li
No Abstract
-
Reply to Tang et al Gastroenterology (IF 25.7) Pub Date : 2024-10-22 Tanawat Geeratragool, Uayporn Kaosombatwattana
No Abstract
-
Detailed information on Cold Snare Resection in Large Colorectal Polyps Gastroenterology (IF 25.7) Pub Date : 2024-10-22 Koki Nakajima, Hiroaki Saito, Yoshitaka Nishikawa
No Abstract
-
CHRONICLE trial: how cool is cold snaring for endoscopic mucosal resection? Gastroenterology (IF 25.7) Pub Date : 2024-10-22 Avinash Tiwari
No Abstract
-
Enhancing Cold Snare Endoscopic Mucosal Resection: Addressing Efficacy Concerns and Margin Management Gastroenterology (IF 25.7) Pub Date : 2024-10-21 Jia Xu, Xiaowei Tang
No Abstract
-
International expert guidance for defining and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound: a consensus statement Gastroenterol. Hepatol. (IF 30.9) Pub Date : 2024-10-22 Cathy Lu, Ryan Rosentreter, Claire E Parker, Julie Remillard, Stephanie R Wilson, Mark E Baker, Gauraang Bhatnagar, Jakob Begun, David H Bruining, Robert V Bryant, Britt Christensen, Brian G Feagan, Joel G Fletcher, Ilyssa Gordon, Gaylyn Henderson, Vipul Jairath, John Knudsen, Torsten Kucharzik, Kyle Lesack, Christian Maaser, Florian Rieder
BackgroundDiagnostic imaging using CT enterography, magnetic resonance enterography, and intestinal ultrasound are important tools in evaluating stricturing Crohn's disease. Definitions of strictures have been developed for CT enterography and magnetic resonance enterography. However, expert recommendations for definitions and treatment response of strictures on intestinal ultrasound are not available
-
UEG Week 2024 Gastroenterol. Hepatol. (IF 30.9) Pub Date : 2024-10-22 Rob Brierley
Section snippets Cendakimab for eosinophilic oesophagitisCendakimab, a monoclonal antibody that inhibits IL-13 binding to both IL-13Rα1 and IL-13Rα2, improved 24-week outcomes in patients with eosinophilic oesophagitis, according to data presented by Alain M Schoepfer (Lausanne, Switzerland). In a phase 3 trial, adults and adolescents with active eosinophilic oesophagitis were randomly assigned to
-
Gut microbial metabolic signatures in diabetes mellitus and potential preventive and therapeutic applications Gut Microbes (IF 12.2) Pub Date : 2024-10-18 Enriqueta Garcia-Gutierrez, A. Kate O’Mahony, Reinaldo Sousa Dos Santos, Laura Marroquí, Paul D. Cotter
Diabetes mellitus can be subdivided into several categories based on origin and clinical characteristics. The most common forms of diabetes are type 1 (T1D), type 2 diabetes (T2D) and gestational d...
-
Inflammasome activation links enteric Salmonella Typhimurium infection to a rapid, cytokine-dependent increase in intestinal mucin release Gut Microbes (IF 12.2) Pub Date : 2024-10-20 Xiao Han, Joannie M. Allaire, Shauna M. Crowley, Jocelyn J. Chan, Kelly Lau, Conghao Zhang, Simon A. Hirota, Kirk Bergstrom, Leigh A. Knodler, Bruce A. Vallance
The host restricts Salmonella enterica serovar Typhimurium infection of the gut via inflammasome-dependent sloughing of infected epithelial cells. Here we determined that concurrent caspase 1/11-de...
-
Gut microbiota determines the fate of dietary fiber-targeted interventions in host health Gut Microbes (IF 12.2) Pub Date : 2024-10-17 Wenjing Wang, Zhexin Fan, Qingqing Yan, Tong Pan, Jing Luo, Yijiang Wei, Baokun Li, Zhifeng Fang, Wenwei Lu
Epidemiological investigation confirmed that the intake of dietary fiber (DF) is closely related to human health, and the most important factor affecting the physiological function of DF, besides i...
-
Comments on “Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes” Gastroenterology (IF 25.7) Pub Date : 2024-10-18 James Cheng-Chung Wei, Ching-Nung Wu, Wei-Chun Cheng
No Abstract
-
GLP-1 Receptor Agonists' Role in Reducing Hepatocellular Carcinoma Risk Gastroenterology (IF 25.7) Pub Date : 2024-10-18 Zaoqu Liu, Dan Shan, Xinwei Han
No Abstract
-
Insights into the protective role of GLP-1RAs in the treatment of type 2 diabetes mellitus: implications for hepatocellular carcinoma and hepatic dysfunction Gastroenterology (IF 25.7) Pub Date : 2024-10-18 Ziyi Wang, Jun Li, Yaling Li
No Abstract
-
Prospective Analysis of Liver Stiffness Measurement by Vibration Controlled Transient Elastography as a Predictor of Outcomes in Biliary Atresia Gastroenterology (IF 25.7) Pub Date : 2024-10-18 Jean P. Molleston, Nathan P. Goodrich, Wen Ye, Daniel H. Leung, Ronald J. Sokol, Benjamin L. Shneider
No Abstract
-
Methodology of Study on GLP-1 Receptor Agonists and Hepatocellular Carcinoma Risk Gastroenterology (IF 25.7) Pub Date : 2024-10-18 James Cheng-Chung Wei, Poi Kuo, Qi Mei
No Abstract
-
A “How-to” Guide For Establishing an Effective Trainee Mentorship Program Gastroenterology (IF 25.7) Pub Date : 2024-10-18 Kirstie Lithgow, Jordan Iannuzzi, Kelle Hurd, Suqing Li
No Abstract
-
Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis Gastroenterology (IF 25.7) Pub Date : 2024-10-18 Ashwin N. Ananthakrishnan, M. Hassan Murad, Frank I. Scott, Manasi Agrawal, John P. Haydek, Berkeley N. Limketkai, Edward V. Loftus, Siddharth Singh
Background & AimsWe performed an updated systematic review and network meta-analysis to inform the 2024 American Gastroenterological Association (AGA) Clinical Guidelines on the management of moderate-to-severe ulcerative colitis (UC). MethodsWe searched multiple electronic databases through November 21, 2023, to identify randomized controlled trials in adults with moderate-to-severe UC, comparing
-
Evolutionary Medicine for Chronic Inflammatory Diseases of the Gut: More than a Clinical Fantasy? Gastroenterology (IF 25.7) Pub Date : 2024-10-18 Nadia Andrea Andreani, Daniel Unterweger, Stefan Schreiber, John F. Baines
No Abstract
-
-
-
-
Elsewhere in The AGA Journals (Preview Section) Gastroenterology (IF 25.7) Pub Date : 2024-10-18
No Abstract
-
Disparities in Gastrointestinal Health for US Immigrant Populations, and Strategies to Address These Disparities Gastroenterology (IF 25.7) Pub Date : 2024-10-18 Miguel Malespin, Saikiran M. Kilaru
Section snippets Colorectal Cancer ScreeningDespite efforts to increase participation in colorectal cancer screening (CCS) in the United States, rates still fall well below the national goal overall, and particularly for IP.4 Universal factors associated with lower CCS within IP include residence in rural communities, lack of health insurance, and limited English proficiency.5 There is also heterogeneity
-
CME Exam 1: Gastrointestinal Biofilms: Endoscopic Detection, Disease Relevance, and Therapeutic Strategies Gastroenterology (IF 25.7) Pub Date : 2024-10-18
Section snippets CME/MOC CreditsThe AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.The AGA Institute designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity
-
Actions of thyroid hormones and thyromimetics on the liver Nat. Rev. Gastroenterol. Hepatol. (IF 45.9) Pub Date : 2024-10-17 Rohit A. Sinha, Eveline Bruinstroop, Paul M. Yen
-
HLA DQA1*05 and risk of anti-TNF treatment failure and anti-drug antibody development in children with Crohn's Disease: HLA DQA1*05 and Pediatric Crohn's Disease. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 Jeremy Adler,Joseph A Galanko,Rana Ammoury,Keith J Benkov,Athos Bousvaros,Brendan Boyle,José M Cabrera,Kelly Y Chun,Jill Dorsey,Dawn R Ebach,Ann M Firestine,Ajay S Gulati,Hans H Herfarth,Traci W Jester,Jess L Kaplan,Ian Leibowitz,Tiffany M Linville,Peter A Margolis,Phillip Minar,Zarela Molle-Rios,Jonathan Moses,Kelly Olano,Dinesh S Pashankar,Lisa Pitch,Shehzad A Saeed,Charles M Samson,Kelly Sandberg
OBJECTIVES HLA DQA1*05 has been associated with the development of anti-drug antibodies (ADA) to tumor necrosis factor antagonists (anti-TNF) and treatment failure among adults with Crohn's disease (CD). However, findings from other studies have been inconsistent with limited pediatric data. METHODS We analyzed banked serum from patients with CD < 21 years of age enrolled in COMBINE, a multi-center
-
FOUR-DIMENSIONAL IMPEDANCE MANOMETRY IN ESOPHAGEAL MOTILITY DISORDERS. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 Eric Goudie,Wenjun Kou,John E Pandolfino,Isis K Araujo,Panyavee Pitisuttithum,Sourav Halder,Peter J Kahrilas,Dustin Carlson
OBJECTIVES Four-dimensional high-resolution impedance manometry (4D HRM) uses impedance to estimate esophageal luminal cross-sectional area and track nadir impedance to measure intrabolus pressure (IBP). We aimed to determine whether 4D HRM metrics could define abnormal esophagogastric junction (EGJ) opening between Chicago Classification v4.0 (CCv4.0) motility disorders and compare 4D HRM with functional
-
Transverse colon penetration by migrated intrauterine device: a rare complication. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 Tae-Gyun Lee,Jin-Min Jung,Sun Jung Kim,Chang Woo Kim
-
Refinement of Hy's Law using the Drug-Induced Liver Injury Network Database. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 A Sidney Barritt,Paul H Hayashi,Andrew A Stolz,Huiman Barnhart,Jay H Hoofnagle,
BACKGROUND Hyman Zimmerman observed that hepatocellular (HC) drug-induced liver injury (DILI) with jaundice had a mortality rate of ≥10% (Hy's Law). Hy's Law does not specify the timing of liver tests nor the definition of HC DILI versus cholestatic or mixed (C/M) DILI. We aimed to assess the validity of Hy's Law in the prospective Drug-Induced Liver Injury Network (DILIN) cohort. METHODS Drugs with
-
Treatment preference archetypes in eosinophilic esophagitis and their implications for therapy. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 Joy W Chang,Kelcie Brophy,Kerry A Ryan,Joel H Rubenstein,Evan S Dellon,Lauren P Wallner,Hyungjin Myra Kim,Raymond De Vries
BACKGROUND Little is known about how patients make decisions about and prioritize, therapies and disease management in eosinophilic esophagitis (EoE). We aimed to systematically identify and characterize patient perspectives and attitudes that influence decision making for EoE management. METHODS To understand the diverse attitudes and values of EoE patients, we designed a study using the Q-method
-
Expanding Insights on Ambulatory Reflux Monitoring: Future Directions and Clinical Integration. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 Francesco Calabrese,Andrea Pasta,Edoardo Vincenzo Savarino,Vincenzo Savarino,Edoardo Giovanni Giannini,Elisa Marabotto
-
Solitary Colonic Ganglioneuroma with Central Depression: A Rare Case with Unique Morphology. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 Masachika Saino,Toshio Kuwai,Shiro Oka
-
Improving the Diagnostic Accuracy of RECAM in North American Patients with Suspected Idiosyncratic Drug-Induced Liver Injury: Improving RECAM accuracy. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 Jacob Ciricillo,Adam Myer,Amoah Yeboah-Korang,Askanda Osman,Farrah Rahim,David G Goldfarb,Yeshika Sharma,Jeremy Louissaint,Kenneth E Sherman,Robert J Fontana
BACKGROUND The RECAM is an updated, electronic version of the RUCAM to diagnose DILI. The primary aim of this study was to compare RECAM versus RUCAM in patients with suspected DILI. METHODS Patient encounters from 10/1/2015 to 9/30/2019 were searched for suspected DILI using ICD-10 K71 codes for toxic liver disease. DILIN expert opinion scores were assigned to each case (1/2/3= probable DILI, 4/5=
-
Disproportionately Increasing Incidence of Inflammatory Bowel Disease in Females and the Elderly: An Update Analysis from the Global Burden of Disease Study 2021. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 Pojsakorn Danpanichkul,Kwanjit Duangsonk,Agnes Hy Ho,Passisd Laoveeravat,Chawinthorn Vuthithammee,Disatorn Dejvajara,Vitchapong Prasitsumrit,Thanida Auttapracha,Busara Songtanin,Panu Wetwittayakhlang,Rashid N Lui,Gursimran Singh Kochhar,Siew C Ng,Francis A Farraye,Karn Wijarnpreecha
OBJECTIVE To update the global burden of Inflammatory Bowel Disease (IBD) using data from the Global Burden of Disease (GBD) 2021. METHODS Data from GBD 2021 were analyzed to assess the IBD burden. RESULTS In 2021, there were 375,140 new cases and 3.83 million total cases of IBD. Elderly-onset IBD accounted for 11% of incidences. 167 countries increased IBD incidence rate, with rates rising in females
-
Letter: Enhancing Predictive Models for Paediatric Ulcerative Colitis—Addressing Socioeconomic, Environmental and Clinical Factors. Authors' Reply Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-10-18 Merle Claßen, Benjamin Schiller, Jan Däbritz
Click on the article title to read more.
-
Letter: Enhancing Predictive Models for Paediatric Ulcerative Colitis—Addressing Socioeconomic, Environmental and Clinical Factors Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-10-18 Aga Luo
Click on the article title to read more.
-
Faecal Volatile Organic Compounds to Detect Colorectal Neoplasia in Lynch Syndrome—A Prospective Longitudinal Multicentre Study Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-10-18 Elsa L. S. A. van Liere, Dewkoemar Ramsoekh, Emma Daulton, Maya Dakkak, Joris M. van Lingen, Trenton K. Stewart, Sofie Bosch, Beatriz Carvalho, Evelien Dekker, Maarten A. J. M. Jacobs, Jan Jacob Koornstra, Johan P. Kuijvenhoven, Monique E. van Leerdam, Tim G. J. de Meij, Gerrit A. Meijer, Manon C. W. Spaander, James A. Covington, Nanne K. H. de Boer
-
High-fat diet-induced L-saccharopine accumulation inhibits estradiol synthesis and damages oocyte quality by disturbing mitochondrial homeostasis Gut Microbes (IF 12.2) Pub Date : 2024-10-16 Jingyi Wen, Yanzhi Feng, Liru Xue, Suzhen Yuan, Qian Chen, Aiyue Luo, Shixuan Wang, Jinjin Zhang
High-fat diet (HFD) has been linked to female infertility. However, the specific age at which HFD impacts ovarian function and the underlying mechanisms remain poorly understood. Here, we administe...
-
AGA Clinical Practice Update on Advances in Per-Oral Endoscopic Myotomy (POEM) and Remaining Questions—What We Have Learned in the Past Decade: Expert Review Gastroenterology (IF 25.7) Pub Date : 2024-10-16 Dennis Yang, Robert Bechara, Christy M. Dunst, Vani J.A. Konda
DescriptionThis American Gastroenterological Association (AGA) Institute Clinical Practice Update (CPU) aims to review the available evidence and provide expert advice regarding advances in per-oral endoscopic myotomy (POEM). MethodsThis CPU was commissioned and approved by the AGA Institute CPU Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance
-
In Memoriam: Ikuo Hirano, MD Gastroenterology (IF 25.7) Pub Date : 2024-10-16 Nirmala Gonsalves, Steven Flamm, Gary W. Falk, David A. Katzka
Section snippets Dr Hirano, the ResearcherDr Hirano’s interest in esophageal diseases was ignited under the mentorship of the great GI physiologist, Dr Raj Goyal. In Dr Goyal’s laboratory, Ikuo completed critical basic science work helping to define esophageal physiology. This work included examining the effect of galanin and the role of tyrosine phosphorylation on esophageal peristalsis. He even published
-
Letter: Gut microbiota—An overlooked therapeutic target in the prevention of post‐operative recurrence of Crohn's disease Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-10-17 D. Bogatic, R. V. Bryant
LINKED CONTENTThis article is linked to Bak et al paper. To view this article, visit https://doi.org/10.1111/apt.18240.
-
Editorial: Advanced glycation end products ‐ a dietary culprit for IBD in the genetically susceptible? Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-10-17 Fahim Ebrahimi, Anders Forss
LINKED CONTENTThis article is linked to Jiang et al paper. To view this article, visit https://doi.org/10.1111/apt.18218
-
Editorial: To Stop Or Not To Stop: Is It Still A Question? Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-10-17 Stephan R. Vavricka, Thomas Greuter
Treatment approaches for inflammatory bowel disease (IBD) have changed considerably within the last two decades. Biological agents and small molecules have dramatically lifted the therapeutic ceiling. The treat-to-target concept is increasingly implemented with the latest STRIDE-II guidelines summarising the key goals as symptomatic response and remission, normalisation of C-reactive protein and decrease
-
Editorial: To Stop or Not to Stop, Is It Still a Question? Authors' Reply Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-10-17 Jeongkuk Seo, Byong Duk Ye
We sincerely thank Vavricka et al. for their thoughtful insights on our study [1, 2]. Their editorial offers a timely and relevant discussion of topics such as mucosal healing, the top-down strategy and treatment de-escalation, all of which represent important shifts in the management of inflammatory bowel disease (IBD) [3-5]. Due to space constraints, we were unable to cover these aspects in sufficient
-
Editorial: Enhancing targeted screening of people living with HIV for liver fibrosis Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-10-17 Shui‐Shan Lee, Grace Chung‐Yan Lui
LINKED CONTENTThis article is linked to Allende et al paper. To view this article, visit https://doi.org/10.1111/apt.18236.
-
Letter: Muddle of serum sPD‐1 and sPD‐L1 levels and association with HBsAg clearance in HBeAg‐negative CHB patients on IFN therapy Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-10-17 Ankur Jindal
LINKED CONTENTThis article is linked to Chen et al paper. To view this article, visit https://doi.org/10.1111/apt.18131.
-
Letter: Allostatic load—A potential key in the development of inflammatory bowel disease Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-10-17 Maryam Kharal, Muhammad Hassan Shahbaz, Muhammad Salman Nadeem, Sana Shahbaz
LINKED CONTENTThis article is linked to Zhao et al paper. To view this article, visit https://doi.org/10.1111/apt.18217.
-
Editorial: Viral hepatitis elimination: Still a big challenge: Care is not only for C Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-10-17 Nikolaos Papadopoulos, Melanie Deutsch
LINKED CONTENTThis article is linked to Vargas‐Accarino et al paper. To view this article, visit https://doi.org/10.1111/apt.18227.
-
Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT-UC Consortium Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-10-15 Parambir S. Dulai, Lauren Balmert Bonner, Charlotte Sadler, Laura E. Raffals, Gursimran Kochhar, Peter Lindholm, Jay C. Buckey, Gary N. Toups, Libeth Rosas, Neeraj Narula, Vipul Jairath, Sailish Honap, Laurent Peyrin-Biroulet, Bruce E. Sands, Stephen B. Hanauer, Denise M. Scholtens, Corey A. Siegel
-
Reply to Wang et al, Wei et al, Liu et al, and Wei et al Gastroenterology (IF 25.7) Pub Date : 2024-10-16 Rong Xu
No Abstract
-
Entamoeba muris mitigates metabolic consequences of high-fat diet in mice Gut Microbes (IF 12.2) Pub Date : 2024-10-13 Maryline Roy, Anne Dumay, Sandrine Adiba, Sylvana Rozes, Seiki Kobayashi, Valérie Paradis, Catherine Postic, Dominique Rainteau, Eric Ogier-Denis, Maud Le Gall, Ulrich Meinzer, Emilie Viennois, Maite Casado-Bedmar, Alexis Mosca, Jean-Pierre Hugot
Metabolic syndrome (MetS) is a cluster of several human conditions including abdominal obesity, hypertension, dyslipidemia, and hyperglycemia, all of which are risk factors of type 2 diabetes, card...
-
Clostridium sporogenes-derived metabolites protect mice against colonic inflammation Gut Microbes (IF 12.2) Pub Date : 2024-10-14 Felix F. Krause, Kira I. Mangold, Anna-Lena Ruppert, Hanna Leister, Anne Hellhund-Zingel, Aleksandra Lopez Krol, Jelena Pesek, Bernhard Watzer, Sarah Winterberg, Hartmann Raifer, Kai Binder, Ralf Kinscherf, Alesia Walker, Wolfgang A. Nockher, R. Verena Taudte, Wilhelm Bertrams, Bernd Schmeck, Anja A. Kühl, Britta Siegmund, Rossana Romero, Maik Luu, Stephan Göttig, Isabelle Bekeredjian-Ding, Ulrich
Gut microbiota-derived metabolites play a pivotal role in the maintenance of intestinal immune homeostasis. Here, we demonstrate that the human commensal Clostridium sporogenes possesses a specific...
-
Controlled infection with cryopreserved human hookworm induces CTLA-4 expression on Tregs and upregulates tryptophan metabolism Gut Microbes (IF 12.2) Pub Date : 2024-10-16 Francesco Vacca, Thomas C. Mules, Mali Camberis, Brittany Lavender, Sophia-Louise Noble, Alissa Cait, Kate Maclean, John Mamum, Bibek Yumnam, Tama Te Kawa, Laura Ferrer-Font, Jeffry S. Tang, Olivier Gasser, Graham Le Gros, Stephen Inns
Infecting humans with controlled doses of helminths, such as human hookworm (termed hookworm therapy), is proposed to prevent or treat various intestinal and extraintestinal diseases. However, full...
-
QUAIDE - Quality assessment of AI preclinical studies in diagnostic endoscopy Gut (IF 23.0) Pub Date : 2024-10-15 Giulio Antonelli, Diogo Libanio, Albert Jeroen De Groof, Fons van der Sommen, Pietro Mascagni, Pieter Sinonquel, Mohamed Abdelrahim, Omer Ahmad, Tyler Berzin, Pradeep Bhandari, Michael Bretthauer, Miguel Coimbra, Evelien Dekker, Alanna Ebigbo, Tom Eelbode, Leonardo Frazzoni, Seth A Gross, Ryu Ishihara, Michal Filip Kaminski, Helmut Messmann, Yuichi Mori, Nicolas Padoy, Sravanthi Parasa, Nastazja Dagny
Artificial intelligence (AI) holds significant potential for enhancing quality of gastrointestinal (GI) endoscopy, but the adoption of AI in clinical practice is hampered by the lack of rigorous standardisation and development methodology ensuring generalisability. The aim of the Quality Assessment of pre-clinical AI studies in Diagnostic Endoscopy (QUAIDE) Explanation and Checklist was to develop
-
Author Correction: Classifying compounds as prebiotics — scientific perspectives and recommendations Nat. Rev. Gastroenterol. Hepatol. (IF 45.9) Pub Date : 2024-10-16 Robert Hutkins, Jens Walter, Glenn R. Gibson, Cassandre Bedu-Ferrari, Karen Scott, Daniel J. Tancredi, Anisha Wijeyesekera, Mary Ellen Sanders
Correction to: Nature Reviews Gastroenterology & Hepatology https://doi.org/10.1038/s41575-024-00981-6, published online 2 October 2024.
-
Neurons on a Mission: Glial Global Positioning System for the Gut Reboot! Gastroenterology (IF 25.7) Pub Date : 2024-10-16 Chalystha Yie Qin Lee, Kara Gross Margolis
No Abstract
-
Comparing the Performance of Commonly Used Fecal Immunochemical Tests Gastroenterology (IF 25.7) Pub Date : 2024-10-15 Nauzer Forbes
No Abstract
-
Placebo rates in Crohn’s disease randomized clinical trials: An individual patient data meta-analysis Gastroenterology (IF 25.7) Pub Date : 2024-10-15 Virginia Solitano, Malcolm Hogan, Siddharth Singh, Silvio Danese, Laurent Peyrin-Biroulet, Guangyong Zou, Yuhong Yuan, Bruce E. Sands, Brian G. Feagan, Parambir S. Dulai, Neeraj Narula, Christopher Ma, Vipul Jairath